Dianthus Therapeutics, Inc. (DNTH) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 1.56B |
| Enterprise Value | 1.51B |
| P/E Ratio | -854.62 |
| PEG Ratio | 141.09 |
| Price/Sales Ratio | 3,263.82 |
| Price/Book Ratio | 5.31 |
| Enterprise/Revenue | 3,206.43 |
| Enterprise/EBITDA | -206.88 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -15.71 |
| Operating Margin | -114.41 |
| Return On Assets | -0.02 |
| Return On Equity | -0.04 |
| Revenue | 2.04M |
| Revenue/Share | 0.03 |
| Gross Profit | 2.04M |
| EBITDA | -161.91M |
| Net Income | -162.34M |
| Diluted EPS | -4.2 |
| Total Cash | 886.81M |
| Total Cash/Share | 15.83 |
| Total Debt | 1.29M |
| Total Debt/Equity | 0 |
| Current Ratio | 26.1 |
| Book Value Per Share | 20.92 |
| 52-Week Change | 374.58 |
| 52-Week High | 117.88 |
| 52-Week Low | 22.81 |
| Moving Average 50 Days | 100.38 |
| Moving Average 200 Days | 72.41 |
| Average Volume | 1.07M |
| Shares Outstanding | 55.93M |
| % Held by Institutions | 137.55 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:16 |
| Last Split Date | September 12, 2023 |